Some norms and reliability data for the State‐Trait Anxiety Inventory and the Zung Self‐Rating Depression scale

Knight, Robert G.; Waal‐Manning, Hendrika J.; Spears, G. F. S.

doi:10.1111/j.2044-8260.1983.tb00610.x

Cited by 599 publications

(449 citation statements)

References 0 publications

Supporting

Mentioning

401

Contrasting

Unclassified

Order By: Relevance

“…However, both genders showed significant improvement in HRQoL afterward. The worse HRQoL among females was predominantly in the physical domains of the NHP, concurring with findings for both healthy people and populations with chronic lung diseases in previous studies 21, 29, 30, 31, 32, 33. According to those studies, this difference in HRQoL is not related to the difference in the severity of the symptoms between males and females.…”

Section: Discussionsupporting

confidence: 90%

“…The improvement in HRQoL remained relatively steady from the first year after LTx to the end of follow‐up. After transplantation, most patients reported an HRQoL comparable to that of the general population 21. However, posttransplantation patients had a higher level of depression compared to values for the general population sample ( P < .001) 17…”

Section: Resultsmentioning

confidence: 87%

See 1 more Smart Citation

Patient-reported health outcomes in long-term lung transplantation survivors: A prospective cohort study

Parizi

Krabbe

Verschuuren

et al. 2018

American Journal of Transplantation

View full text Add to dashboard Cite

During the last three decades lung transplantation (LTx) has become a proven modality for increasing both survival and health‐related quality of life (HRQoL) in patients with various end‐stage lung diseases. Most previous studies have reported improved HRQoL shortly after LTx. With regard to long‐term effects on HRQoL, however, the evidence is less solid. This prospective cohort study was started with 828 patients who were on the waiting list for LTx. Then, in a longitudinal follow‐up, 370 post‐LTx patients were evaluated annually for up to 15 years. For all wait‐listed and follow‐up patients, the following four HRQoL instruments were administered: State‐Trait Anxiety Inventory, Zung Self‐rating Depression Scale, Nottingham Health Profile, and a visual analogue scale. Cross‐sectional and generalized estimating equation (GEE) analysis for repeated measures were performed to assess changes in HRQoL during follow‐up. After LTx, patients showed improvement in all HRQoL domains except pain, which remained steady throughout the long‐term follow‐up. The level of anxiety and depressive symptoms decreased significantly and remained constant. In conclusion, this study showed that HRQoL improves after LTx and tends to remain relatively constant for the entire life span.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Resultsmentioning

confidence: 87%

Patient-reported health outcomes in long-term lung transplantation survivors: A prospective cohort study

Parizi

Krabbe

Verschuuren

et al. 2018

American Journal of Transplantation

View full text Add to dashboard Cite

show abstract

“…Anxiety proneness was significantly higher in our sample than in Knight et al's (1983) general population. The psychological characteristics (trait anxiety, locus of control and monitoring/ blunting) observed in this sample were very similar to those observed in the familial breast clinic sample (Cull et al, 1999).…”

Section: Discussioncontrasting

confidence: 67%

“…Knight et al (1983) collected STAI data from a general population sample in an area of New Zealand with a strong history of immigration from Scotland. The STAI trait anxiety scores which they present by age (in 10-year bands) and sex offer more appropriate reference data for this study than those in the STAI manual which are derived from employees in the US Federal Aviation Administration.…”

Section: Anxiety Pronenessmentioning

confidence: 99%

Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic

et al. 2001

View full text Add to dashboard Cite

SummaryOf 230 women referred to a familial ovarian cancer clinic, 196 (85%) completed a questionnaire before they attended. The data collected included pre-counselling risk perceptions and an assessment of distress. Respondents were more likely to underestimate (44%) than overestimate (19%) their risk. Those with a family history of breast and ovarian cancer (HBOC) were particularly likely to underestimate their ovarian cancer risk. The variables assessed in this study -sociodemographic, family history, distress, anxiety proneness, coping style and beliefs about health control -explained little of the observed variation in accuracy of risk perception. On the General Health Questionnaire (GHQ-30) 30% of the sample obtained scores above the cut-off (≥ 6) recommended for screening for 'case-level' psychological distress. Women exhibiting case-level distress were more likely to overestimate their risk (OR = 2.3). On univariate analysis low internal locus of control was associated with 'case-level' distress (P = 0.008). On multiple regression the best predictors of 'caseness' were high-trait anxiety, being a graduate and inaccurate risk perception. There was no difference in the level of distress shown by women with HBOC vs. those with a history of ovarian cancer only. Implications of these findings for the counselling needs of the women are discussed. The effectiveness of the clinic in improving the accuracy of risk perceptions and relieving distress is being assessed.

show abstract

“…Published norms were applied. Neurobehavioral testing included the Geriatric Depression Scale (GDS), State – Trait Anxiety Inventory (STAI), and Questionnaire for Impulsive‐Compulsive Disorders (QUIP) 13, 14, 15. Additional assessments included Epworth Sleepiness Scale and a REM sleep behavior disorder (RBD) questionnaire to assess sleep behavior, Scales for Outcomes in Parkinson's Disease‐Autonomic (SCOPA‐AUT) to assess autonomic function, and the 40‐item University of Pennsylvania Smell Identification Test (UPSIT) to assess olfactory function.…”

Section: Methodsmentioning

confidence: 99%

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Marek

Chowdhury

Siderowf

et al. 2018

Ann Clin Transl Neurol

399

339

View full text Add to dashboard Cite

ObjectiveThe Parkinson's Progression Markers Initiative (PPMI) is an observational, international study designed to establish biomarker‐defined cohorts and identify clinical, imaging, genetic, and biospecimen Parkinson's disease (PD) progression markers to accelerate disease‐modifying therapeutic trials.MethodsA total of 423 untreated PD, 196 Healthy Control (HC) and 64 SWEDD (scans without evidence of dopaminergic deficit) subjects were enrolled at 24 sites. To enroll PD subjects as early as possible following diagnosis, subjects were eligible with only asymmetric bradykinesia or tremor plus a dopamine transporter (DAT) binding deficit on SPECT imaging. Acquisition of data was standardized as detailed at www.ppmi-info.org.ResultsApproximately 9% of enrolled subjects had a single PD sign at baseline. DAT imaging excluded 16% of potential PD subjects with SWEDD. The total MDS‐UPDRS for PD was 32.4 compared to 4.6 for HC and 28.2 for SWEDD. On average, PD subjects demonstrated 45% and 68% reduction in mean striatal and contralateral putamen Specific Binding Ratios (SBR), respectively. Cerebrospinal fluid (CSF) was acquired from >97% of all subjects. CSF (PD/HC/SWEDD pg/mL) α‐synuclein (1845/2204/2141) was reduced in PD vs HC or SWEDD (P < 0.03). Similarly, t‐tau (45/53) and p‐tau (16/18) were reduced in PD versus HC (P < 0.01),Interpretation PPMI has detailed the biomarker signature for an early PD cohort defined by clinical features and imaging biomarkers. This strategy provides the framework to establish biomarker cohorts and to define longitudinal progression biomarkers to support future PD treatment trials.

show abstract

Some norms and reliability data for the State‐Trait Anxiety Inventory and the Zung Self‐Rating Depression scale

Cited by 599 publications

References 0 publications

Patient-reported health outcomes in long-term lung transplantation survivors: A prospective cohort study

Patient-reported health outcomes in long-term lung transplantation survivors: A prospective cohort study

Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Contact Info

Product

Resources

About